Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alogliptin Add-on to Sulfonylurea in Japanese T2DM
NCT01318083Phase 3Completed
- Sponsor
- Takeda
- Start
- Aug 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of alogliptin in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Aug 2008; status: completed.
02
Drugs
alogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01318083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01318083.